1.4M XNAS Volume
XNAS 18 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Stephen A. Sherwin | Director | Sale of securities on an exchange or to another person at price $ 150.02 per share. | 07 Mar 2025 | 8,760 | 11,318 (0%) | 0% | 150.0 | 1,314,142 | Common Stock |
| Susan H. Alexander | EVP Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 2,575 | 0 | - | - | Restricted Stock Unit | |
| Michael R. Mcdonnell | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 142.54 per share. | 10 Feb 2025 | 1,371 | 24,341 (0%) | 0% | 142.5 | 195,422 | Common Stock |
| Michael R. Mcdonnell | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 3,257 | 0 | - | - | Restricted Stock Unit | |
| Michael R. Mcdonnell | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 3,257 | 25,712 (0%) | 0% | 0 | Common Stock | |
| Susan H. Alexander | EVP Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 142.54 per share. | 10 Feb 2025 | 807 | 36,265 (0%) | 0% | 142.5 | 115,030 | Common Stock |
| Susan H. Alexander | EVP Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 2,575 | 37,072 (0%) | 0% | 0 | Common Stock | |
| Ginger Gregory | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 142.54 per share. | 10 Feb 2025 | 634 | 17,598 (0%) | 0% | 142.5 | 90,370 | Common Stock |
| Ginger Gregory | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 2,159 | 18,232 (0%) | 0% | 0 | Common Stock | |
| Ginger Gregory | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 2,159 | 0 | - | - | Restricted Stock Unit | |
| Robin C. Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 834 | 8,256 (0%) | 0% | 0 | Common Stock | |
| Robin C. Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 834 | 0 | - | - | Restricted Stock Unit | |
| Priya Singhal | Head of Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 142.54 per share. | 10 Feb 2025 | 357 | 9,066 (0%) | 0% | 142.5 | 50,887 | Common Stock |
| Robin C. Kramer | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 142.54 per share. | 10 Feb 2025 | 245 | 8,011 (0%) | 0% | 142.5 | 34,922 | Common Stock |
| Priya Singhal | Head of Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 1,212 | 9,423 (0%) | 0% | 0 | Common Stock | |
| Priya Singhal | Head of Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 1,212 | 0 | - | - | Restricted Stock Unit | |
| Rachid Izzar | Head of Global Product Strat. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 142.54 per share. | 10 Feb 2025 | 445 | 8,553 (0%) | 0% | 142.5 | 63,430 | Common Stock |
| Rachid Izzar | Head of Global Product Strat. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 1,515 | 8,998 (0%) | 0% | 0 | Common Stock | |
| Rachid Izzar | Head of Global Product Strat. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 1,515 | 0 | - | - | Restricted Stock Unit | |
| Nicole Murphy | Head of Pharm Ops and Tech | Payment of exercise price or tax liability using portion of securities received from the company at price $ 142.54 per share. | 10 Feb 2025 | 670 | 14,055 (0%) | 0% | 142.5 | 95,502 | Common Stock |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 2,272 | 14,725 (0%) | 0% | 0 | Common Stock | |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 2,272 | 0 | - | - | Restricted Stock Unit | |
| Rachid Izzar | Head of Global Product Strat. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 1,801 | 7,860 (0%) | 0% | 0 | Common Stock | |
| Rachid Izzar | Head of Global Product Strat. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 2,043 | 2,044 | - | - | Restricted Stock Unit | |
| Rachid Izzar | Head of Global Product Strat. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 2,043 | 7,224 (0%) | 0% | 0 | Common Stock | |
| Rachid Izzar | Head of Global Product Strat. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.35 per share. | 07 Feb 2025 | 600 | 6,624 (0%) | 0% | 141.4 | 84,810 | Common Stock |
| Rachid Izzar | Head of Global Product Strat. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.35 per share. | 07 Feb 2025 | 565 | 6,059 (0%) | 0% | 141.4 | 79,863 | Common Stock |
| Rachid Izzar | Head of Global Product Strat. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 1,801 | 3,604 | - | - | Restricted Stock Unit | |
| Michael R. Mcdonnell | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.35 per share. | 07 Feb 2025 | 716 | 22,455 (0%) | 0% | 141.4 | 101,207 | Common Stock |
| Michael R. Mcdonnell | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 2,335 | 2,335 | - | - | Restricted Stock Unit | |
| Michael R. Mcdonnell | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 2,216 | 4,434 | - | - | Restricted Stock Unit | |
| Michael R. Mcdonnell | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 2,335 | 21,741 (0%) | 0% | 0 | Common Stock | |
| Michael R. Mcdonnell | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.35 per share. | 07 Feb 2025 | 786 | 20,955 (0%) | 0% | 141.3 | 111,101 | Common Stock |
| Michael R. Mcdonnell | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 2,216 | 23,171 (0%) | 0% | 0 | Common Stock | |
| Jane Grogan | Head of Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 1,385 | 1,876 (0%) | 0% | 0 | Common Stock | |
| Priya Singhal | Head of Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 14,050 | 14,050 | - | - | Restricted Stock Unit | |
| Jane Grogan | Head of Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.35 per share. | 06 Feb 2025 | 443 | 1,433 (0%) | 0% | 141.3 | 62,618 | Common Stock |
| Jane Grogan | Head of Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 1,385 | 2,770 | - | - | Restricted Stock Unit | |
| Rachid Izzar | Head of Global Product Strat. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 9,130 | 9,130 | - | - | Restricted Stock Unit | |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 2,102 | 2,102 | - | - | Restricted Stock Unit | |
| Nicole Murphy | Head of Pharm Ops and Tech | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 14,050 | 14,050 | - | - | Restricted Stock Unit | |
| Nicole Murphy | Head of Pharm Ops and Tech | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.35 per share. | 06 Feb 2025 | 603 | 12,453 (0%) | 0% | 141.3 | 85,234 | Common Stock |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 1,940 | 13,056 (0%) | 0% | 0 | Common Stock | |
| Nicole Murphy | Head of Pharm Ops and Tech | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.35 per share. | 06 Feb 2025 | 620 | 11,116 (0%) | 0% | 141.4 | 87,637 | Common Stock |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 2,102 | 11,736 (0%) | 0% | 0 | Common Stock | |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 1,940 | 3,880 | - | - | Restricted Stock Unit | |
| Adam Keeney | Head of Corporate Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 9,835 | 9,835 | - | - | Restricted Stock Unit | |
| Adam Keeney | Head of Corporate Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 1,801 | 3,604 | - | - | Restricted Stock Unit | |
| Adam Keeney | Head of Corporate Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 1,801 | 2,463 (0%) | 0% | 0 | Common Stock | |
| Adam Keeney | Head of Corporate Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.35 per share. | 06 Feb 2025 | 563 | 1,900 (0%) | 0% | 141.3 | 79,580 | Common Stock |
| Priya Singhal | Head of Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 2,216 | 8,892 (0%) | 0% | 0 | Common Stock | |
| Christopher A. Viehbacher | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 9,008 | 18,017 | - | - | Restricted Stock Unit | |
| Christopher A. Viehbacher | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 46,360 | 46,360 | - | - | Restricted Stock Unit | |
| Christopher A. Viehbacher | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 9,008 | 16,008 (0%) | 0% | 0 | Common Stock | |
| Christopher A. Viehbacher | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.35 per share. | 06 Feb 2025 | 3,201 | 12,807 (0%) | 0% | 141.3 | 452,461 | Common Stock |
| Susan H. Alexander | EVP Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.35 per share. | 06 Feb 2025 | 643 | 33,148 (0%) | 0% | 141.3 | 90,888 | Common Stock |
| Susan H. Alexander | EVP Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.35 per share. | 06 Feb 2025 | 591 | 34,497 (0%) | 0% | 141.4 | 83,538 | Common Stock |
| Susan H. Alexander | EVP Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 14,750 | 14,750 | - | - | Restricted Stock Unit | |
| Susan H. Alexander | EVP Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 2,190 | 2,190 | - | - | Restricted Stock Unit | |
| Susan H. Alexander | EVP Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 1,940 | 3,880 | - | - | Restricted Stock Unit | |
| Susan H. Alexander | EVP Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 2,190 | 33,791 (0%) | 0% | 0 | Common Stock | |
| Susan H. Alexander | EVP Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 1,940 | 35,088 (0%) | 0% | 0 | Common Stock | |
| Ginger Gregory | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 1,801 | 16,633 (0%) | 0% | 0 | Common Stock | |
| Ginger Gregory | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 1,635 | 15,312 (0%) | 0% | 0 | Common Stock | |
| Ginger Gregory | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.35 per share. | 06 Feb 2025 | 480 | 14,832 (0%) | 0% | 141.4 | 67,848 | Common Stock |
| Ginger Gregory | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 11,240 | 11,240 | - | - | Restricted Stock Unit | |
| Jane Grogan | Head of Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 5,620 | 5,620 | - | - | Restricted Stock Unit | |
| Priya Singhal | Head of Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 2,216 | 4,434 | - | - | Restricted Stock Unit | |
| Priya Singhal | Head of Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.35 per share. | 06 Feb 2025 | 681 | 8,211 (0%) | 0% | 141.3 | 96,259 | Common Stock |
| Robin C. Kramer | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.35 per share. | 06 Feb 2025 | 232 | 6,963 (0%) | 0% | 141.3 | 32,793 | Common Stock |
| Robin C. Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 703 | 1,407 | - | - | Restricted Stock Unit | |
| Robin C. Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 788 | 789 | - | - | Restricted Stock Unit | |
| Robin C. Kramer | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.35 per share. | 06 Feb 2025 | 244 | 7,422 (0%) | 0% | 141.3 | 34,489 | Common Stock |
| Robin C. Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 703 | 7,666 (0%) | 0% | 0 | Common Stock | |
| Robin C. Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 788 | 7,195 (0%) | 0% | 0 | Common Stock | |
| Ginger Gregory | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 1,801 | 3,604 | - | - | Restricted Stock Unit | |
| Robin C. Kramer | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 10,535 | 10,535 | - | - | Restricted Stock Unit | |
| Ginger Gregory | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 1,635 | 1,635 | - | - | Restricted Stock Unit | |
| Ginger Gregory | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.35 per share. | 06 Feb 2025 | 560 | 16,073 (0%) | 0% | 141.4 | 79,156 | Common Stock |
| Priya Singhal | Head of Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 1,828 | 7,254 (0%) | 0% | 0 | Common Stock | |
| Priya Singhal | Head of Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 143.93 per share. | 31 Jan 2025 | 578 | 6,676 (0%) | 0% | 143.9 | 83,192 | Common Stock |
| Priya Singhal | Head of Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 1,828 | 1,829 | - | - | Restricted Stock Unit | |
| Priya Singhal | Head of Development | Sale of securities on an exchange or to another person at price $ 157.21 per share. | 06 Dec 2024 | 110 | 5,426 (0%) | 0% | 157.2 | 17,293 | Common Stock |
| Priya Singhal | Head of Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 426 | 5,742 (0%) | 0% | 0 | Common Stock | |
| Priya Singhal | Head of Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 157.78 per share. | 06 Dec 2024 | 206 | 5,536 (0%) | 0% | 157.8 | 32,503 | Common Stock |
| Priya Singhal | Head of Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 426 | 0 | - | - | Restricted Stock Unit | |
| Robin C. Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 351 | 0 | - | - | Restricted Stock Unit | |
| Robin C. Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 351 | 6,577 (0%) | 0% | 0 | Common Stock | |
| Robin C. Kramer | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 157.78 per share. | 06 Dec 2024 | 170 | 6,407 (0%) | 0% | 157.8 | 26,823 | Common Stock |
| Susan H. Alexander | EVP Chief Legal Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Nov 2024 | 20,082 | 31,601 (0%) | 0% | 0 | Common Stock | |
| Susan H. Alexander | EVP Chief Legal Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Nov 2024 | 20,082 | 20,082 (0%) | 0% | 0 | Common Stock | |
| Jane Grogan | Head of Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 695 | 695 (0%) | 0% | 0 | Common Stock | |
| Jane Grogan | Head of Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 173.79 per share. | 01 Nov 2024 | 204 | 491 (0%) | 0% | 173.8 | 35,453 | Common Stock |
| Jane Grogan | Head of Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 695 | 1,390 | - | - | Restricted Stock Unit | |
| Priya Singhal | Head of Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Aug 2024 | 1,668 | 1,669 | - | - | Restricted Stock Unit | |
| Priya Singhal | Head of Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Aug 2024 | 1,668 | 6,554 (0%) | 0% | 0 | Common Stock | |
| Priya Singhal | Head of Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 204.76 per share. | 30 Aug 2024 | 807 | 5,747 (0%) | 0% | 204.8 | 165,241 | Common Stock |
| Priya Singhal | Head of Development | Sale of securities on an exchange or to another person at price $ 204.22 per share. | 30 Aug 2024 | 431 | 5,316 (0%) | 0% | 204.2 | 88,019 | Common Stock |
| Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 1,785 | 26,607 (0%) | 0% | 0 | Common Stock | |
| Eric K. Rowinsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 1,340 | 21,969 (0%) | 0% | 0 | Common Stock | |
| William A. Hawkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 1,340 | 6,490 (0%) | 0% | 0 | Common Stock | |
| Stephen A. Sherwin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 1,340 | 20,078 (0%) | 0% | 0 | Common Stock | |
| Maria C. Freire | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 1,340 | 4,445 (0%) | 0% | 0 | Common Stock | |
| Jesus B. Mantas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 1,340 | 7,388 (0%) | 0% | 0 | Common Stock | |
| Monish D. Patolawala | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 1,340 | 1,340 (0%) | 0% | 0 | Common Stock | |
| Susan Langer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 1,340 | 2,759 (0%) | 0% | 0 | Common Stock | |
| Adam Keeney | Head of Corporate Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 216.13 per share. | 01 May 2024 | 276 | 662 (0%) | 0% | 216.1 | 59,652 | Common Stock |
| Adam Keeney | Head of Corporate Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 938 | 1,877 | - | - | Restricted Stock Unit | |
| Adam Keeney | Head of Corporate Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 938 | 938 (0%) | 0% | 0 | Common Stock | |
| Priya Singhal | Head of Development | Sale of securities on an exchange or to another person at price $ 213.09 per share. | 02 Apr 2024 | 93 | 4,886 (0%) | 0% | 213.1 | 19,817 | Common Stock |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 240 | 9,751 (0%) | 0% | 0 | Common Stock | |
| Nicole Murphy | Head of Pharm Ops and Tech | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.83 per share. | 01 Apr 2024 | 117 | 9,634 (0%) | 0% | 214.8 | 25,135 | Common Stock |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 240 | 0 | - | - | Restricted Stock Unit | |
| Singhal Priya | Head of Development | Sale of securities on an exchange or to another person at price $ 221.23 per share. | 22 Feb 2024 | 262 | 4,886 (0%) | 0% | 221.2 | 57,962 | Common Stock |
| H. Alexander Susan | EVP Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 219.08 per share. | 16 Feb 2024 | 1,656 | 50,850 (0%) | 0% | 219.1 | 362,796 | Common Stock |
| Kramer C. Robin | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 914 | 6,191 (0%) | 0% | 0 | Common Stock | |
| Ginger Gregory | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 1,507 | 1,879 | - | - | Restricted Stock Unit | |
| Michael Mcdonnell R. | EVP, Chief Financial Officer | 16 Feb 2024 | 2,684 | 0 | - | - | Restricted Stock Unit | ||
| Robin Kramer C. | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 219.08 per share. | 16 Feb 2024 | 127 | 6,226 (0%) | 0% | 219.1 | 27,823 | Common Stock |
| Nicole Murphy | Head of Pharm Ops and Tech | Payment of exercise price or tax liability using portion of securities received from the company at price $ 219.08 per share. | 16 Feb 2024 | 196 | 9,417 (0%) | 0% | 219.1 | 42,940 | Common Stock |
| Murphy Nicole | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 856 | 9,623 (0%) | 0% | 0 | Common Stock | |
| Priya Singhal | Head of Development | Sale of securities on an exchange or to another person at price $ 221.49 per share. | 16 Feb 2024 | 108 | 5,148 (0%) | 0% | 221.5 | 23,921 | Common Stock |
| Priya Singhal | Head of Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 219.08 per share. | 16 Feb 2024 | 173 | 5,256 (0%) | 0% | 219.1 | 37,901 | Common Stock |
| Murphy Nicole | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 404 | 504 | - | - | Restricted Stock Unit | |
| Kramer C. Robin | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 431 | 537 | - | - | Restricted Stock Unit | |
| Susan H. Alexander | EVP Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 3,423 | 0 | - | - | Performance Stock Unit | |
| R. Mcdonnell Michael | EVP, Chief Financial Officer | 16 Feb 2024 | 1,101 | 19,406 (0%) | 0% | 219.1 | 241,207 | Common Stock | |
| Mcdonnell R. Michael | EVP, Chief Financial Officer | 16 Feb 2024 | 2,152 | 20,507 (0%) | 0% | 0 | Common Stock | ||
| Gregory Ginger | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 219.08 per share. | 16 Feb 2024 | 1,535 | 12,805 (0%) | 0% | 219.1 | 336,288 | Common Stock |
| Izzar Rachid | Head of Global Product Strat. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 647 | 807 | - | - | Restricted Stock Unit | |
| Mcdonnell Michael R. | EVP, Chief Financial Officer | 16 Feb 2024 | 2,152 | 2,684 | - | - | Restricted Stock Unit | ||
| Rachid Izzar | Head of Global Product Strat. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 219.08 per share. | 16 Feb 2024 | 313 | 9,701 (0%) | 0% | 219.1 | 68,572 | Common Stock |
| Gregory Ginger | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 219.08 per share. | 16 Feb 2024 | 729 | 13,583 (0%) | 0% | 219.1 | 159,709 | Common Stock |
| Izzar Rachid | Head of Global Product Strat. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 647 | 10,014 (0%) | 0% | 0 | Common Stock | |
| Susan H. Alexander | EVP Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 1,614 | 52,464 (0%) | 0% | 0 | Common Stock | |
| Robin Kramer C. | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 431 | 6,353 (0%) | 0% | 0 | Common Stock | |
| H. Alexander Susan | EVP Chief Legal Officer | Other type of transaction at price $ 0.00 per share. | 16 Feb 2024 | 2,012 | 0 | - | - | Restricted Stock Unit | |
| Izzar Rachid | Head of Global Product Strat. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 1,370 | 0 | - | - | Performance Stock Unit | |
| C. Robin Kramer | Chief Accounting Officer | Other type of transaction at price $ 0.00 per share. | 16 Feb 2024 | 537 | 0 | - | - | Restricted Stock Unit | |
| Izzar Rachid | Head of Global Product Strat. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 219.08 per share. | 16 Feb 2024 | 639 | 9,367 (0%) | 0% | 219.1 | 139,992 | Common Stock |
| Murphy Nicole | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 856 | 0 | - | - | Performance Stock Unit | |
| Murphy Nicole | Head of Pharm Ops and Tech | Other type of transaction at price $ 0.00 per share. | 16 Feb 2024 | 504 | 0 | - | - | Restricted Stock Unit | |
| Singhal Priya | Head of Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 219.08 per share. | 16 Feb 2024 | 295 | 5,040 (0%) | 0% | 219.1 | 64,629 | Common Stock |
| Murphy Nicole | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 404 | 9,613 (0%) | 0% | 0 | Common Stock | |
| Susan H. Alexander | EVP Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 1,614 | 2,012 | - | - | Restricted Stock Unit | |
| R. Michael Mcdonnell | EVP, Chief Financial Officer | 16 Feb 2024 | 2,337 | 18,355 (0%) | 0% | 219.1 | 511,990 | Common Stock | |
| Mcdonnell R. Michael | EVP, Chief Financial Officer | 16 Feb 2024 | 4,568 | 20,692 (0%) | 0% | 0 | Common Stock | ||
| Singhal Priya | Head of Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 389 | 485 | - | - | Restricted Stock Unit | |
| Gregory Ginger | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 3,197 | 14,340 (0%) | 0% | 0 | Common Stock | |
| Izzar Rachid | Head of Global Product Strat. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 1,370 | 10,006 (0%) | 0% | 0 | Common Stock | |
| Gregory Ginger | EVP, Human Resources | Other type of transaction at price $ 0.00 per share. | 16 Feb 2024 | 1,879 | 0 | - | - | Restricted Stock Unit | |
| Nicole Murphy | Head of Pharm Ops and Tech | Payment of exercise price or tax liability using portion of securities received from the company at price $ 219.08 per share. | 16 Feb 2024 | 414 | 9,209 (0%) | 0% | 219.1 | 90,699 | Common Stock |
| Singhal Priya | Head of Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 819 | 0 | - | - | Performance Stock Unit | |
| Mcdonnell Michael R. | EVP, Chief Financial Officer | 16 Feb 2024 | 4,568 | 0 | - | - | Performance Stock Unit | ||
| Singhal Priya | Head of Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 389 | 5,429 (0%) | 0% | 0 | Common Stock | |
| Ginger Gregory | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 1,507 | 14,312 (0%) | 0% | 0 | Common Stock | |
| Singhal Priya | Head of Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 819 | 5,335 (0%) | 0% | 0 | Common Stock | |
| Priya Singhal | Head of Development | Other type of transaction at price $ 0.00 per share. | 16 Feb 2024 | 485 | 0 | - | - | Restricted Stock Unit | |
| Kramer C. Robin | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 914 | 0 | - | - | Performance Stock Unit | |
| Ginger Gregory | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 3,197 | 0 | - | - | Performance Stock Unit | |
| Rachid Izzar | Head of Global Product Strat. | Other type of transaction at price $ 0.00 per share. | 16 Feb 2024 | 807 | 0 | - | - | Restricted Stock Unit | |
| C. Robin Kramer | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 219.08 per share. | 16 Feb 2024 | 269 | 5,922 (0%) | 0% | 219.1 | 58,933 | Common Stock |
| Susan H. Alexander | EVP Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 3,423 | 52,506 (0%) | 0% | 0 | Common Stock | |
| Alexander Susan H. | EVP Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 219.08 per share. | 16 Feb 2024 | 781 | 51,683 (0%) | 0% | 219.1 | 171,101 | Common Stock |
| Rowinsky K. Eric | Director | Purchase of securities on an exchange or from another person at price $ 222.54 per share. | 15 Feb 2024 | 455 | 20,629 (0%) | 0% | 222.5 | 101,256 | Common Stock |
| C. Robin Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 833 | 5,522 (0%) | 0% | 0 | Common Stock | |
| Rachid Izzar | Head of Global Product Strat. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 1,515 | 9,081 (0%) | 0% | 0 | Common Stock | |
| Nicole Murphy | Head of Pharm Ops and Tech | Payment of exercise price or tax liability using portion of securities received from the company at price $ 240.98 per share. | 09 Feb 2024 | 761 | 8,767 (0%) | 0% | 241.0 | 183,386 | Common Stock |
| Robin C. Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 833 | 834 | - | - | Restricted Stock Unit | |
| Alexander Susan H. | EVP Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 240.98 per share. | 09 Feb 2024 | 938 | 49,083 (0%) | 0% | 241.0 | 226,039 | Common Stock |
| Susan H. Alexander | EVP Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 2,575 | 50,021 (0%) | 0% | 0 | Common Stock | |
| Priya Singhal | Head of Development | Sale of securities on an exchange or to another person at price $ 239.45 per share. | 09 Feb 2024 | 419 | 4,516 (0%) | 0% | 239.5 | 100,330 | Common Stock |
| Gregory Ginger | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 240.98 per share. | 09 Feb 2024 | 634 | 11,143 (0%) | 0% | 241.0 | 152,781 | Common Stock |
| R. Mcdonnell Michael | EVP, Chief Financial Officer | 09 Feb 2024 | 1,431 | 16,124 (0%) | 0% | 241.0 | 344,842 | Common Stock | |
| Susan H. Alexander | EVP Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 2,575 | 2,575 | - | - | Restricted Stock Unit | |
| Gregory Ginger | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 2,158 | 2,159 | - | - | Restricted Stock Unit | |
| Rachid Izzar | Head of Global Product Strat. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 1,515 | 1,515 | - | - | Restricted Stock Unit | |
| Robin Kramer C. | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 240.98 per share. | 09 Feb 2024 | 245 | 5,277 (0%) | 0% | 241.0 | 59,040 | Common Stock |
| Mcdonnell Michael R. | EVP, Chief Financial Officer | 09 Feb 2024 | 3,257 | 17,555 (0%) | 0% | 0 | Common Stock | ||
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 2,272 | 9,528 (0%) | 0% | 0 | Common Stock | |
| Priya Singhal | Head of Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 240.98 per share. | 09 Feb 2024 | 374 | 4,935 (0%) | 0% | 241.0 | 90,127 | Common Stock |
| Murphy Nicole | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 2,272 | 2,272 | - | - | Restricted Stock Unit | |
| Singhal Priya | Head of Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 1,212 | 1,212 | - | - | Restricted Stock Unit | |
| Izzar Rachid | Head of Global Product Strat. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 240.98 per share. | 09 Feb 2024 | 445 | 8,636 (0%) | 0% | 241.0 | 107,236 | Common Stock |
| Mcdonnell R. Michael | EVP, Chief Financial Officer | 09 Feb 2024 | 3,257 | 3,257 | - | - | Restricted Stock Unit | ||
| Singhal Priya | Head of Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 1,212 | 5,309 (0%) | 0% | 0 | Common Stock | |
| Ginger Gregory | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 2,158 | 11,777 (0%) | 0% | 0 | Common Stock | |
| Rachid Izzar | Head of Global Product Strat. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 240.30 per share. | 07 Feb 2024 | 621 | 7,566 (0%) | 0% | 240.3 | 149,226 | Common Stock |
| Susan H. Alexander | EVP Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 2,190 | 4,380 | - | - | Restricted Stock Unit | |
| Grogan Jane | Head of Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2024 | 4,155 | 4,155 | - | - | Restricted Stock Unit | |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 2,101 | 7,894 (0%) | 0% | 0 | Common Stock | |
| Murphy Nicole | Head of Pharm Ops and Tech | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2024 | 5,820 | 5,820 | - | - | Restricted Stock Unit | |
| Alexander Susan H. | EVP Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 2,190 | 48,101 (0%) | 0% | 0 | Common Stock | |
| Michael Mcdonnell R. | EVP, Chief Financial Officer | 07 Feb 2024 | 765 | 14,298 (0%) | 0% | 240.3 | 183,830 | Common Stock | |
| Murphy Nicole | Head of Pharm Ops and Tech | Payment of exercise price or tax liability using portion of securities received from the company at price $ 240.30 per share. | 07 Feb 2024 | 638 | 7,256 (0%) | 0% | 240.3 | 153,311 | Common Stock |
| Ginger Gregory | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 1,635 | 3,270 | - | - | Restricted Stock Unit | |
| Alexander H. Susan | EVP Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2024 | 5,820 | 5,820 | - | - | Restricted Stock Unit | |
| Ginger Gregory | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 1,635 | 10,117 (0%) | 0% | 0 | Common Stock | |
| Izzar Rachid | Head of Global Product Strat. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2024 | 5,405 | 5,405 | - | - | Restricted Stock Unit | |
| C. Kramer Robin | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 788 | 4,942 (0%) | 0% | 0 | Common Stock | |
| Kramer C. Robin | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2024 | 2,110 | 2,110 | - | - | Restricted Stock Unit | |
| Michael R. Mcdonnell | EVP, Chief Financial Officer | 07 Feb 2024 | 2,335 | 15,063 (0%) | 0% | 0 | Common Stock | ||
| Adam Keeney | Head of Corporate Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2024 | 5,405 | 5,405 | - | - | Restricted Stock Unit | |
| Izzar Rachid | Head of Global Product Strat. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 2,043 | 4,087 | - | - | Restricted Stock Unit | |
| Michael Mcdonnell R. | EVP, Chief Financial Officer | 07 Feb 2024 | 2,335 | 4,670 | - | - | Restricted Stock Unit | ||
| Kramer Robin C. | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 240.30 per share. | 07 Feb 2024 | 253 | 4,689 (0%) | 0% | 240.3 | 60,796 | Common Stock |
| Viehbacher Christopher A. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2024 | 27,025 | 27,025 | - | - | Restricted Stock Unit | |
| Gregory Ginger | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 240.30 per share. | 07 Feb 2024 | 498 | 9,619 (0%) | 0% | 240.3 | 119,669 | Common Stock |
| Susan H. Alexander | EVP Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 240.30 per share. | 07 Feb 2024 | 655 | 47,446 (0%) | 0% | 240.3 | 157,397 | Common Stock |
| Michael Mcdonnell R. | EVP, Chief Financial Officer | 07 Feb 2024 | 6,650 | 6,650 | - | - | Restricted Stock Unit | ||
| Priya Singhal | Head of Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2024 | 6,650 | 6,650 | - | - | Restricted Stock Unit | |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 2,101 | 4,204 | - | - | Restricted Stock Unit | |
| Rachid Izzar | Head of Global Product Strat. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 2,043 | 8,187 (0%) | 0% | 0 | Common Stock | |
| Gregory Ginger | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2024 | 5,405 | 5,405 | - | - | Restricted Stock Unit | |
| Kramer Robin C. | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 788 | 1,577 | - | - | Restricted Stock Unit | |
| Singhal Priya | Head of Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 1,828 | 3,657 | - | - | Restricted Stock Unit | |
| Priya Singhal | Head of Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 1,828 | 5,292 (0%) | 0% | 0 | Common Stock | |
| Priya Singhal | Head of Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 247.83 per share. | 01 Feb 2024 | 561 | 4,731 (0%) | 0% | 247.8 | 139,033 | Common Stock |
| Priya Singhal | Head of Development | Sale of securities on an exchange or to another person at price $ 245.93 per share. | 01 Feb 2024 | 634 | 4,097 (0%) | 0% | 245.9 | 155,920 | Common Stock |
| Ginger Gregory | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 3,197 | 3,197 | - | - | Performance Stock Unit | |
| H. Susan Alexander | EVP Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 3,423 | 3,423 | - | - | Performance Stock Unit | |
| Singhal Priya | Head of Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 819 | 819 | - | - | Performance Stock Unit | |
| Mcdonnell Michael R. | EVP, Chief Financial Officer | 29 Jan 2024 | 4,568 | 4,568 | - | - | Performance Stock Unit | ||
| Rachid Izzar | Head of Global Product Strat. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 1,370 | 1,370 | - | - | Performance Stock Unit | |
| Nicole Murphy | Head of Pharm Ops and Tech | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 856 | 856 | - | - | Performance Stock Unit | |
| Robin C. Kramer | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 914 | 914 | - | - | Performance Stock Unit | |
| Robin C. Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2023 | 351 | 351 | - | - | Restricted Stock Unit | |
| C. Kramer Robin | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2023 | 351 | 4,324 (0%) | 0% | 0 | Common Stock | |
| Priya Singhal | Head of Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 239.29 per share. | 08 Dec 2023 | 206 | 3,574 (0%) | 0% | 239.3 | 49,294 | Common Stock |
| Kramer Robin C. | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 239.29 per share. | 08 Dec 2023 | 170 | 4,154 (0%) | 0% | 239.3 | 40,679 | Common Stock |
| Priya Singhal | Head of Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2023 | 426 | 3,780 (0%) | 0% | 0 | Common Stock | |
| Priya Singhal | Head of Development | Sale of securities on an exchange or to another person at price $ 248.00 per share. | 08 Dec 2023 | 110 | 3,464 (0%) | 0% | 248 | 27,280 | Common Stock |
| Priya Singhal | Head of Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2023 | 426 | 426 | - | - | Restricted Stock Unit | |
| Robin C. Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 252 | 0 | - | - | Restricted Stock Unit | |
| Robin C. Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 252 | 4,095 (0%) | 0% | 0 | Common Stock | |
| Robin C. Kramer | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 284.85 per share. | 30 Jun 2023 | 122 | 3,973 (0%) | 0% | 284.9 | 34,752 | Common Stock |
| Priya Singhal | Head of Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 284.85 per share. | 30 Jun 2023 | 153 | 3,005 (0%) | 0% | 284.8 | 43,582 | Common Stock |
| Priya Singhal | Head of Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 315 | 0 | - | - | Restricted Stock Unit | |
| Priya Singhal | Head of Development | Sale of securities on an exchange or to another person at price $ 282.86 per share. | 30 Jun 2023 | 81 | 2,924 (0%) | 0% | 282.9 | 22,912 | Common Stock |
| Priya Singhal | Head of Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 315 | 3,158 (0%) | 0% | 0 | Common Stock | |
| Rachid Izzar | Head of Global Product Strat. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 504 | 6,388 (0%) | 0% | 0 | Common Stock | |
| Rachid Izzar | Head of Global Product Strat. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 284.85 per share. | 30 Jun 2023 | 244 | 6,144 (0%) | 0% | 284.8 | 69,503 | Common Stock |
| Rachid Izzar | Head of Global Product Strat. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 504 | 0 | - | - | Restricted Stock Unit | |
| Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 1,580 | 24,822 (0%) | 0% | 0 | Common Stock | |
| Eric K. Rowinsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 960 | 20,174 (0%) | 0% | 0 | Common Stock | |
| William A. Hawkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 960 | 5,150 (0%) | 0% | 0 | Common Stock | |
| Stephen A. Sherwin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 960 | 18,738 (0%) | 0% | 0 | Common Stock | |
| Maria C. Freire | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 960 | 3,105 (0%) | 0% | 0 | Common Stock | |
| Jesus B. Mantas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 960 | 6,048 (0%) | 0% | 0 | Common Stock | |
| Susan Langer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 960 | 1,419 (0%) | 0% | 0 | Common Stock | |
| Adam Keeney | Head of Corporate Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2023 | 2,815 | 2,815 | - | - | Restricted Stock Unit | |
| Ginger Gregory | EVP, Human Resources | Sale of securities on an exchange or to another person at price $ 300.00 per share. | 28 Apr 2023 | 2,681 | 8,482 (0%) | 0% | 300 | 804,300 | Common Stock |
| Priya Singhal | Head of Development | Sale of securities on an exchange or to another person at price $ 277.11 per share. | 04 Apr 2023 | 91 | 2,843 (0%) | 0% | 277.1 | 25,217 | Common Stock |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 239 | 5,818 (0%) | 0% | 0 | Common Stock | |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 239 | 240 | - | - | Restricted Stock Unit | |
| Nicole Murphy | Head of Pharm Ops and Tech | Payment of exercise price or tax liability using portion of securities received from the company at price $ 278.03 per share. | 31 Mar 2023 | 116 | 5,702 (0%) | 0% | 278.0 | 32,251 | Common Stock |
| Priya Singhal | Head of Development | Sale of securities on an exchange or to another person at price $ 270.06 per share. | 28 Mar 2023 | 568 | 2,842 (0%) | 0% | 270.1 | 153,394 | Common Stock |
| Priya Singhal | Head of Development | Other type of transaction at price $ 0.00 per share. | 02 Mar 2023 | 341 | 0 | - | - | Restricted Stock Unit | |
| Priya Singhal | Head of Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 297 | 341 | - | - | Restricted Stock Unit | |
| Priya Singhal | Head of Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 268.75 per share. | 02 Mar 2023 | 144 | 3,410 (0%) | 0% | 268.8 | 38,700 | Common Stock |
| Priya Singhal | Head of Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 297 | 3,554 (0%) | 0% | 0 | Common Stock | |
| Priya Singhal | Head of Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 268.75 per share. | 02 Mar 2023 | 543 | 3,257 (0%) | 0% | 268.7 | 145,931 | Common Stock |
| Michael R. Mcdonnell | EVP, Chief Financial Officer | 17 Feb 2023 | 2,561 | 7,107 | - | - | Restricted Stock Unit | ||
| Michael R. Mcdonnell | EVP, Chief Financial Officer | 17 Feb 2023 | 2,271 | 4,836 | - | - | Restricted Stock Unit | ||
| Michael R. Mcdonnell | EVP, Chief Financial Officer | 17 Feb 2023 | 2,561 | 10,147 (0%) | 0% | 0 | Common Stock | ||
| Michael R. Mcdonnell | EVP, Chief Financial Officer | 17 Feb 2023 | 1,310 | 7,586 (0%) | 0% | 278.4 | 364,678 | Common Stock | |
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 278.38 per share. | 17 Feb 2023 | 929 | 45,911 (0%) | 0% | 278.4 | 258,615 | Common Stock |
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 1,920 | 46,840 (0%) | 0% | 0 | Common Stock | |
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Other type of transaction at price $ 0.00 per share. | 17 Feb 2023 | 1,702 | 3,626 | - | - | Restricted Stock Unit | |
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 1,920 | 5,328 | - | - | Restricted Stock Unit | |
| Ginger Gregory | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 1,792 | 4,976 | - | - | Restricted Stock Unit | |
| Ginger Gregory | EVP, Human Resources | Other type of transaction at price $ 0.00 per share. | 17 Feb 2023 | 1,590 | 3,386 | - | - | Restricted Stock Unit | |
| Ginger Gregory | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 1,792 | 11,072 (0%) | 0% | 0 | Common Stock | |
| Ginger Gregory | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 278.38 per share. | 17 Feb 2023 | 867 | 9,280 (0%) | 0% | 278.4 | 241,355 | Common Stock |
| Robin C. Kramer | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 278.38 per share. | 17 Feb 2023 | 238 | 3,331 (0%) | 0% | 278.4 | 66,254 | Common Stock |
| Robin C. Kramer | Chief Accounting Officer | Other type of transaction at price $ 0.00 per share. | 17 Feb 2023 | 454 | 968 | - | - | Restricted Stock Unit | |
| Robin C. Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 512 | 1,422 | - | - | Restricted Stock Unit | |
| Robin C. Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 512 | 3,843 (0%) | 0% | 0 | Common Stock | |
| Priya Singhal | Head of Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 460 | 3,951 (0%) | 0% | 0 | Common Stock | |
| Priya Singhal | Head of Development | Other type of transaction at price $ 0.00 per share. | 17 Feb 2023 | 408 | 874 | - | - | Restricted Stock Unit | |
| Priya Singhal | Head of Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 460 | 1,282 | - | - | Restricted Stock Unit | |
| Priya Singhal | Head of Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 278.38 per share. | 17 Feb 2023 | 151 | 3,800 (0%) | 0% | 278.4 | 42,035 | Common Stock |
| Rachid Izzar | Head of Global Product Strat. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 767 | 2,135 | - | - | Restricted Stock Unit | |
| Rachid Izzar | Head of Global Product Strat. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 767 | 5,884 (0%) | 0% | 0 | Common Stock | |
| Rachid Izzar | Head of Global Product Strat. | Other type of transaction at price $ 0.00 per share. | 17 Feb 2023 | 681 | 1,454 | - | - | Restricted Stock Unit | |
| Rachid Izzar | Head of Global Product Strat. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 278.38 per share. | 17 Feb 2023 | 371 | 5,117 (0%) | 0% | 278.4 | 103,279 | Common Stock |
| Nicole Murphy | Head of Pharm Ops and Tech | Other type of transaction at price $ 0.00 per share. | 17 Feb 2023 | 426 | 908 | - | - | Restricted Stock Unit | |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 480 | 5,579 (0%) | 0% | 0 | Common Stock | |
| Nicole Murphy | Head of Pharm Ops and Tech | Payment of exercise price or tax liability using portion of securities received from the company at price $ 278.38 per share. | 17 Feb 2023 | 233 | 5,099 (0%) | 0% | 278.4 | 64,863 | Common Stock |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 480 | 1,334 | - | - | Restricted Stock Unit | |
| Michael R. Mcdonnell | EVP, Chief Financial Officer | 10 Feb 2023 | 1,105 | 8,896 (0%) | 0% | 286.3 | 316,362 | Common Stock | |
| Michael R. Mcdonnell | EVP, Chief Financial Officer | 10 Feb 2023 | 3,256 | 10,001 (0%) | 0% | 0 | Common Stock | ||
| Michael R. Mcdonnell | EVP, Chief Financial Officer | 10 Feb 2023 | 3,256 | 6,514 | - | - | Restricted Stock Unit | ||
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 2,575 | 47,674 (0%) | 0% | 0 | Common Stock | |
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 2,575 | 5,150 | - | - | Restricted Stock Unit | |
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Other type of transaction at price $ 0.00 per share. | 10 Feb 2023 | 1,770 | 0 | - | - | Restricted Stock Unit | |
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 1,448 | 1,770 | - | - | Restricted Stock Unit | |
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 286.30 per share. | 10 Feb 2023 | 701 | 47,657 (0%) | 0% | 286.3 | 200,696 | Common Stock |
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 1,448 | 48,358 (0%) | 0% | 0 | Common Stock | |
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 286.30 per share. | 10 Feb 2023 | 764 | 46,910 (0%) | 0% | 286.3 | 218,733 | Common Stock |
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 286.30 per share. | 10 Feb 2023 | 2,737 | 44,920 (0%) | 0% | 286.3 | 783,603 | Common Stock |
| Ginger Gregory | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 2,158 | 4,317 | - | - | Restricted Stock Unit | |
| Ginger Gregory | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 2,158 | 12,321 (0%) | 0% | 0 | Common Stock | |
| Ginger Gregory | EVP, Human Resources | Other type of transaction at price $ 0.00 per share. | 10 Feb 2023 | 1,384 | 0 | - | - | Restricted Stock Unit | |
| Ginger Gregory | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 286.30 per share. | 10 Feb 2023 | 648 | 11,673 (0%) | 0% | 286.3 | 185,522 | Common Stock |
| Ginger Gregory | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 1,132 | 1,384 | - | - | Restricted Stock Unit | |
| Ginger Gregory | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 286.30 per share. | 10 Feb 2023 | 2,110 | 10,147 (0%) | 0% | 286.3 | 604,093 | Common Stock |
| Ginger Gregory | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 286.30 per share. | 10 Feb 2023 | 548 | 12,257 (0%) | 0% | 286.3 | 156,892 | Common Stock |
| Ginger Gregory | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 1,132 | 12,805 (0%) | 0% | 0 | Common Stock | |
| Robin C. Kramer | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 286.30 per share. | 10 Feb 2023 | 67 | 3,830 (0%) | 0% | 286.3 | 19,182 | Common Stock |
| Robin C. Kramer | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 286.30 per share. | 10 Feb 2023 | 262 | 3,669 (0%) | 0% | 286.3 | 75,011 | Common Stock |
| Robin C. Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 833 | 3,931 (0%) | 0% | 0 | Common Stock | |
| Robin C. Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 833 | 1,667 | - | - | Restricted Stock Unit | |
| Robin C. Kramer | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 286.30 per share. | 10 Feb 2023 | 261 | 3,569 (0%) | 0% | 286.3 | 74,724 | Common Stock |
| Robin C. Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 228 | 3,897 (0%) | 0% | 0 | Common Stock | |
| Robin C. Kramer | Chief Accounting Officer | Other type of transaction at price $ 0.00 per share. | 10 Feb 2023 | 278 | 0 | - | - | Restricted Stock Unit | |
| Robin C. Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 228 | 278 | - | - | Restricted Stock Unit | |
| Priya Singhal | Head of Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 1,211 | 2,424 | - | - | Restricted Stock Unit | |
| Priya Singhal | Head of Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 286.30 per share. | 10 Feb 2023 | 372 | 3,491 (0%) | 0% | 286.3 | 106,504 | Common Stock |
| Priya Singhal | Head of Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 1,211 | 3,863 (0%) | 0% | 0 | Common Stock | |
| Rachid Izzar | Head of Global Product Strat. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 453 | 6,350 (0%) | 0% | 0 | Common Stock | |
| Rachid Izzar | Head of Global Product Strat. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 1,515 | 6,359 (0%) | 0% | 0 | Common Stock | |
| Rachid Izzar | Head of Global Product Strat. | Other type of transaction at price $ 0.00 per share. | 10 Feb 2023 | 553 | 0 | - | - | Restricted Stock Unit | |
| Rachid Izzar | Head of Global Product Strat. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 453 | 553 | - | - | Restricted Stock Unit | |
| Rachid Izzar | Head of Global Product Strat. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 1,515 | 3,030 | - | - | Restricted Stock Unit | |
| Rachid Izzar | Head of Global Product Strat. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 286.30 per share. | 10 Feb 2023 | 642 | 5,488 (0%) | 0% | 286.3 | 183,805 | Common Stock |
| Rachid Izzar | Head of Global Product Strat. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 286.30 per share. | 10 Feb 2023 | 220 | 6,130 (0%) | 0% | 286.3 | 62,986 | Common Stock |
| Rachid Izzar | Head of Global Product Strat. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 286.30 per share. | 10 Feb 2023 | 462 | 5,897 (0%) | 0% | 286.3 | 132,271 | Common Stock |
| Nicole Murphy | Head of Pharm Ops and Tech | Payment of exercise price or tax liability using portion of securities received from the company at price $ 286.30 per share. | 10 Feb 2023 | 165 | 5,332 (0%) | 0% | 286.3 | 47,240 | Common Stock |
| Nicole Murphy | Head of Pharm Ops and Tech | Other type of transaction at price $ 0.00 per share. | 10 Feb 2023 | 416 | 0 | - | - | Restricted Stock Unit | |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 340 | 416 | - | - | Restricted Stock Unit | |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 2,271 | 4,544 | - | - | Restricted Stock Unit | |
| Nicole Murphy | Head of Pharm Ops and Tech | Payment of exercise price or tax liability using portion of securities received from the company at price $ 286.30 per share. | 10 Feb 2023 | 537 | 5,497 (0%) | 0% | 286.3 | 153,743 | Common Stock |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 340 | 6,034 (0%) | 0% | 0 | Common Stock | |
| Nicole Murphy | Head of Pharm Ops and Tech | Payment of exercise price or tax liability using portion of securities received from the company at price $ 286.30 per share. | 10 Feb 2023 | 685 | 5,694 (0%) | 0% | 286.3 | 196,116 | Common Stock |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 2,271 | 6,379 (0%) | 0% | 0 | Common Stock | |
| Michael R. Mcdonnell | EVP, Chief Financial Officer | 08 Feb 2023 | 7,005 | 7,005 | - | - | Restricted Stock Unit | ||
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 6,570 | 6,570 | - | - | Restricted Stock Unit | |
| Ginger Gregory | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 4,905 | 4,905 | - | - | Restricted Stock Unit | |
| Robin C. Kramer | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 2,365 | 2,365 | - | - | Restricted Stock Unit | |
| Rachid Izzar | Head of Global Product Strat. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 6,130 | 6,130 | - | - | Restricted Stock Unit | |
| Nicole Murphy | Head of Pharm Ops and Tech | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 6,305 | 6,305 | - | - | Restricted Stock Unit | |
| Priya Singhal | Head of Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 5,485 | 5,485 | - | - | Restricted Stock Unit | |
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 5,703 | 45,099 (0%) | 0% | 0 | Common Stock | |
| Ginger Gregory | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 4,452 | 10,163 (0%) | 0% | 0 | Common Stock | |
| Robin C. Kramer | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 887 | 3,098 (0%) | 0% | 0 | Common Stock | |
| Priya Singhal | Head of Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 1,123 | 2,652 (0%) | 0% | 0 | Common Stock | |
| Rachid Izzar | Head of Alzheimers Disease | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 1,783 | 4,844 (0%) | 0% | 0 | Common Stock | |
| Nicole Murphy | Head of Pharm Ops and Tech | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 1,340 | 4,108 (0%) | 0% | 0 | Common Stock | |
| Brian S. Posner | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 150 | 8,025 (0%) | 0% | 0 | Common Stock | |
| Stephen A. Sherwin | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 695 | 17,778 (0%) | 0% | 0 | Common Stock | |
| Robin C. Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2022 | 350 | 702 | - | - | Restricted Stock Unit | |
| Robin C. Kramer | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 289.10 per share. | 08 Dec 2022 | 156 | 2,211 (0%) | 0% | 289.1 | 45,100 | Common Stock |
| Robin C. Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2022 | 350 | 2,367 (0%) | 0% | 0 | Common Stock | |
| Rachid Izzar | Head of Alzheimers Disease | Payment of exercise price or tax liability using portion of securities received from the company at price $ 298.90 per share. | 02 Dec 2022 | 189 | 3,061 (0%) | 0% | 298.9 | 56,492 | Common Stock |
| Rachid Izzar | Head of Alzheimers Disease | Payment of exercise price or tax liability using portion of securities received from the company at price $ 298.90 per share. | 02 Dec 2022 | 570 | 2,825 (0%) | 0% | 298.9 | 170,373 | Common Stock |
| Rachid Izzar | Head of Alzheimers Disease | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2022 | 425 | 3,250 (0%) | 0% | 0 | Common Stock | |
| Rachid Izzar | Head of Alzheimers Disease | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2022 | 1,285 | 3,395 (0%) | 0% | 0 | Common Stock | |
| Rachid Izzar | Head of Alzheimers Disease | Other type of transaction at price $ 0.00 per share. | 02 Dec 2022 | 433 | 0 | - | - | Restricted Stock Unit | |
| Rachid Izzar | Head of Alzheimers Disease | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2022 | 425 | 433 | - | - | Restricted Stock Unit | |
| Rachid Izzar | Head of Alzheimers Disease | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2022 | 1,285 | 0 | - | - | Restricted Stock Unit | |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2022 | 131 | 0 | - | - | Restricted Stock Unit | |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2022 | 131 | 2,807 (0%) | 0% | 0 | Common Stock | |
| Nicole Murphy | Head of Pharm Ops and Tech | Payment of exercise price or tax liability using portion of securities received from the company at price $ 298.90 per share. | 02 Dec 2022 | 39 | 2,768 (0%) | 0% | 298.9 | 11,657 | Common Stock |
| Christopher A. Viehbacher | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2022 | 45,998 | 45,998 | - | - | Performance Stock Unit | |
| Christopher A. Viehbacher | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2022 | 80,522 | 80,522 | - | - | Stock Option | |
| Christopher A. Viehbacher | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2022 | 7,040 | 7,040 | - | - | Restricted Stock Unit | |
| Ginger Gregory | EVP, Human Resources | Sale of securities on an exchange or to another person at price $ 300.11 per share. | 14 Nov 2022 | 5,610 | 5,711 (0%) | 0% | 300.1 | 1,683,617 | Common Stock |
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Sale of securities on an exchange or to another person at price $ 280.70 per share. | 27 Oct 2022 | 5,532 | 39,396 (0%) | 0% | 280.7 | 1,552,832 | Common Stock |
| Michael R. Mcdonnell | EVP, Chief Financial Officer | 01 Sep 2022 | 1,372 | 5,737 (0%) | 0% | 199.8 | 274,112 | Common Stock | |
| Michael R. Mcdonnell | EVP, Chief Financial Officer | 01 Sep 2022 | 3,298 | 5,366 | - | - | Restricted Stock Unit | ||
| Michael R. Mcdonnell | EVP, Chief Financial Officer | 01 Sep 2022 | 2,064 | 8,664 | - | - | Restricted Stock Unit | ||
| Michael R. Mcdonnell | EVP, Chief Financial Officer | 01 Sep 2022 | 2,682 | 2,682 | - | - | Restricted Stock Unit | ||
| Michael R. Mcdonnell | EVP, Chief Financial Officer | 01 Sep 2022 | 1,056 | 6,745 (0%) | 0% | 199.8 | 210,978 | Common Stock | |
| Michael R. Mcdonnell | EVP, Chief Financial Officer | 01 Sep 2022 | 2,064 | 7,801 (0%) | 0% | 0 | Common Stock | ||
| Michael R. Mcdonnell | EVP, Chief Financial Officer | 01 Sep 2022 | 2,682 | 7,109 (0%) | 0% | 0 | Common Stock | ||
| Nicole Murphy | Head of Pharm Ops and Tech | Payment of exercise price or tax liability using portion of securities received from the company at price $ 209.26 per share. | 01 Aug 2022 | 76 | 2,094 (0%) | 0% | 209.3 | 15,904 | Common Stock |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2022 | 825 | 0 | - | - | Restricted Stock Unit | |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2022 | 255 | 0 | - | - | Restricted Stock Unit | |
| Nicole Murphy | Head of Pharm Ops and Tech | Other type of transaction at price $ 0.00 per share. | 01 Aug 2022 | 299 | 255 | - | - | Restricted Stock Unit | |
| Nicole Murphy | Head of Pharm Ops and Tech | Payment of exercise price or tax liability using portion of securities received from the company at price $ 209.26 per share. | 01 Aug 2022 | 243 | 2,676 (0%) | 0% | 209.3 | 50,850 | Common Stock |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2022 | 825 | 2,919 (0%) | 0% | 0 | Common Stock | |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2022 | 255 | 2,170 (0%) | 0% | 0 | Common Stock | |
| Robin C. Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2022 | 252 | 2,091 (0%) | 0% | 0 | Common Stock | |
| Robin C. Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2022 | 252 | 252 | - | - | Restricted Stock Unit | |
| Robin C. Kramer | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 210.64 per share. | 01 Jul 2022 | 74 | 2,017 (0%) | 0% | 210.6 | 15,587 | Common Stock |
| Rachid Izzar | Head of Alzheimers Disease | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2022 | 504 | 504 | - | - | Restricted Stock Unit | |
| Rachid Izzar | Head of Alzheimers Disease | Payment of exercise price or tax liability using portion of securities received from the company at price $ 210.63 per share. | 01 Jul 2022 | 148 | 2,110 (0%) | 0% | 210.6 | 31,173 | Common Stock |
| Rachid Izzar | Head of Alzheimers Disease | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2022 | 504 | 2,258 (0%) | 0% | 0 | Common Stock | |
| Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 1,370 | 23,242 (0%) | 0% | 0 | Common Stock | |
| Eric K. Rowinsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 1,370 | 19,214 (0%) | 0% | 0 | Common Stock | |
| Stelios Papadopoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 2,255 | 10,095 (0%) | 0% | 0 | Common Stock | |
| William A. Hawkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 1,370 | 4,190 (0%) | 0% | 0 | Common Stock | |
| William D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 1,370 | 2,145 (0%) | 0% | 0 | Common Stock | |
| Stephen A. Sherwin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 1,370 | 18,473 (0%) | 0% | 0 | Common Stock | |
| Richard C. Mulligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 1,370 | 15,099 (0%) | 0% | 0 | Common Stock | |
| Alexander J. Denner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 1,370 | 15,099 (0%) | 0% | 0 | Common Stock | |
| Maria C. Freire | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 1,370 | 2,145 (0%) | 0% | 0 | Common Stock | |
| Jesus B. Mantas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 1,370 | 5,088 (0%) | 0% | 0 | Common Stock | |
| Nicole Murphy | Head of Pharm Ops and Tech | Payment of exercise price or tax liability using portion of securities received from the company at price $ 210.65 per share. | 01 Apr 2022 | 84 | 1,812 (0%) | 0% | 210.7 | 17,695 | Common Stock |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 239 | 479 | - | - | Restricted Stock Unit | |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 239 | 1,896 (0%) | 0% | - | Common Stock | |
| Michael R. Mcdonnell | EVP, Chief Financial Officer | 18 Feb 2022 | 977 | 4,427 (0%) | 0% | 209.8 | 204,965 | Common Stock | |
| Michael R. Mcdonnell | EVP, Chief Financial Officer | 18 Feb 2022 | 2,851 | 9,668 | - | - | Restricted Stock Unit | ||
| Michael R. Mcdonnell | EVP, Chief Financial Officer | 18 Feb 2022 | 1,981 | 12,519 | - | - | Restricted Stock Unit | ||
| Michael R. Mcdonnell | EVP, Chief Financial Officer | 18 Feb 2022 | 1,981 | 5,404 (0%) | 0% | 0 | Common Stock | ||
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 1,485 | 45,587 (0%) | 0% | 0 | Common Stock | |
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Other type of transaction at price $ 0.00 per share. | 18 Feb 2022 | 2,137 | 7,248 | - | - | Restricted Stock Unit | |
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 1,485 | 9,385 | - | - | Restricted Stock Unit | |
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 209.79 per share. | 18 Feb 2022 | 659 | 44,928 (0%) | 0% | 209.8 | 138,252 | Common Stock |
| Ginger Gregory | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 1,387 | 11,834 (0%) | 0% | 0 | Common Stock | |
| Ginger Gregory | EVP, Human Resources | Other type of transaction at price $ 0.00 per share. | 18 Feb 2022 | 1,995 | 6,768 | - | - | Restricted Stock Unit | |
| Ginger Gregory | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 1,387 | 8,763 | - | - | Restricted Stock Unit | |
| Ginger Gregory | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 209.79 per share. | 18 Feb 2022 | 616 | 11,218 (0%) | 0% | 209.8 | 129,231 | Common Stock |
| Robin C. Kramer | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 209.79 per share. | 18 Feb 2022 | 117 | 1,737 (0%) | 0% | 209.8 | 24,545 | Common Stock |
| Robin C. Kramer | Chief Accounting Officer | Other type of transaction at price $ 0.00 per share. | 18 Feb 2022 | 570 | 1,934 | - | - | Restricted Stock Unit | |
| Robin C. Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 396 | 2,504 | - | - | Restricted Stock Unit | |
| Robin C. Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 396 | 1,854 (0%) | 0% | 0 | Common Stock | |
| Michel Vounatsos | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 209.79 per share. | 18 Feb 2022 | 2,746 | 67,261 (0%) | 0% | 209.8 | 576,083 | Common Stock |
| Michel Vounatsos | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 18 Feb 2022 | 8,909 | 30,210 | - | - | Restricted Stock Unit | |
| Michel Vounatsos | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 6,191 | 39,119 | - | - | Restricted Stock Unit | |
| Michel Vounatsos | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 6,191 | 70,007 (0%) | 0% | 0 | Common Stock | |
| Chirfi Guindo | Head of Glob Prod Strat & Com | Other type of transaction at price $ 0.00 per share. | 18 Feb 2022 | 2,851 | 9,668 | - | - | Restricted Stock Unit | |
| Chirfi Guindo | Head of Glob Prod Strat & Com | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 1,981 | 8,243 (0%) | 0% | 0 | Common Stock | |
| Chirfi Guindo | Head of Glob Prod Strat & Com | Payment of exercise price or tax liability using portion of securities received from the company at price $ 209.79 per share. | 18 Feb 2022 | 879 | 7,364 (0%) | 0% | 209.8 | 184,405 | Common Stock |
| Chirfi Guindo | Head of Glob Prod Strat & Com | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 1,981 | 12,519 | - | - | Restricted Stock Unit | |
| Rachid Izzar | Head of Alzheimers Disease | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 594 | 1,929 (0%) | 0% | 0 | Common Stock | |
| Rachid Izzar | Head of Alzheimers Disease | Payment of exercise price or tax liability using portion of securities received from the company at price $ 209.79 per share. | 18 Feb 2022 | 175 | 1,754 (0%) | 0% | 209.8 | 36,713 | Common Stock |
| Rachid Izzar | Head of Alzheimers Disease | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 594 | 3,756 | - | - | Restricted Stock Unit | |
| Rachid Izzar | Head of Alzheimers Disease | Other type of transaction at price $ 0.00 per share. | 18 Feb 2022 | 854 | 2,902 | - | - | Restricted Stock Unit | |
| Nicole Murphy | Head of Pharm Ops and Tech | Other type of transaction at price $ 0.00 per share. | 18 Feb 2022 | 535 | 1,814 | - | - | Restricted Stock Unit | |
| Nicole Murphy | Head of Pharm Ops and Tech | Payment of exercise price or tax liability using portion of securities received from the company at price $ 209.79 per share. | 18 Feb 2022 | 110 | 1,657 (0%) | 0% | 209.8 | 23,077 | Common Stock |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 371 | 2,349 | - | - | Restricted Stock Unit | |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 371 | 1,767 (0%) | 0% | 0 | Common Stock | |
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.59 per share. | 12 Feb 2022 | 500 | 45,146 (0%) | 0% | 214.6 | 107,295 | Common Stock |
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 1,154 | 2,190 | - | - | Restricted Stock Unit | |
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 1,126 | 45,646 (0%) | 0% | 0 | Common Stock | |
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.59 per share. | 12 Feb 2022 | 512 | 44,520 (0%) | 0% | 214.6 | 109,870 | Common Stock |
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 1,154 | 45,032 (0%) | 0% | 0 | Common Stock | |
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Other type of transaction at price $ 0.00 per share. | 12 Feb 2022 | 2,190 | 0 | - | - | Restricted Stock Unit | |
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.59 per share. | 12 Feb 2022 | 1,044 | 44,102 (0%) | 0% | 214.6 | 224,032 | Common Stock |
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Other type of transaction at price $ 0.00 per share. | 12 Feb 2022 | 2,090 | 3,218 | - | - | Restricted Stock Unit | |
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 1,126 | 5,308 | - | - | Restricted Stock Unit | |
| Ginger Gregory | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.59 per share. | 12 Feb 2022 | 278 | 10,542 (0%) | 0% | 214.6 | 59,656 | Common Stock |
| Ginger Gregory | EVP, Human Resources | Other type of transaction at price $ 0.00 per share. | 12 Feb 2022 | 1,633 | 2,516 | - | - | Restricted Stock Unit | |
| Ginger Gregory | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 879 | 4,149 | - | - | Restricted Stock Unit | |
| Ginger Gregory | EVP, Human Resources | Other type of transaction at price $ 0.00 per share. | 12 Feb 2022 | 1,505 | 0 | - | - | Restricted Stock Unit | |
| Ginger Gregory | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 793 | 1,505 | - | - | Restricted Stock Unit | |
| Ginger Gregory | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.59 per share. | 12 Feb 2022 | 584 | 10,447 (0%) | 0% | 214.6 | 125,321 | Common Stock |
| Ginger Gregory | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.59 per share. | 12 Feb 2022 | 390 | 11,031 (0%) | 0% | 214.6 | 83,690 | Common Stock |
| Ginger Gregory | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 879 | 11,421 (0%) | 0% | 0 | Common Stock | |
| Ginger Gregory | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 793 | 10,820 (0%) | 0% | 0 | Common Stock | |
| Robin C. Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 99 | 1,453 (0%) | 0% | 0 | Common Stock | |
| Robin C. Kramer | Chief Accounting Officer | Other type of transaction at price $ 0.00 per share. | 12 Feb 2022 | 326 | 506 | - | - | Restricted Stock Unit | |
| Robin C. Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 176 | 832 | - | - | Restricted Stock Unit | |
| Robin C. Kramer | Chief Accounting Officer | Other type of transaction at price $ 0.00 per share. | 12 Feb 2022 | 189 | 0 | - | - | Restricted Stock Unit | |
| Robin C. Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 99 | 189 | - | - | Restricted Stock Unit | |
| Robin C. Kramer | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.59 per share. | 12 Feb 2022 | 85 | 1,458 (0%) | 0% | 214.6 | 18,240 | Common Stock |
| Robin C. Kramer | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.59 per share. | 12 Feb 2022 | 51 | 1,543 (0%) | 0% | 214.6 | 10,944 | Common Stock |
| Robin C. Kramer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 176 | 1,594 (0%) | 0% | 0 | Common Stock | |
| Robin C. Kramer | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.60 per share. | 12 Feb 2022 | 35 | 1,418 (0%) | 0% | 214.6 | 7,511 | Common Stock |
| Michel Vounatsos | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 4,321 | 8,205 | - | - | Restricted Stock Unit | |
| Michel Vounatsos | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.59 per share. | 12 Feb 2022 | 1,950 | 68,515 (0%) | 0% | 214.6 | 418,451 | Common Stock |
| Michel Vounatsos | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 4,395 | 70,465 (0%) | 0% | 0 | Common Stock | |
| Michel Vounatsos | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.59 per share. | 12 Feb 2022 | 1,917 | 66,070 (0%) | 0% | 214.6 | 411,369 | Common Stock |
| Michel Vounatsos | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 4,321 | 67,987 (0%) | 0% | 0 | Common Stock | |
| Michel Vounatsos | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 12 Feb 2022 | 8,163 | 12,564 | - | - | Restricted Stock Unit | |
| Michel Vounatsos | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 4,395 | 20,727 | - | - | Restricted Stock Unit | |
| Michel Vounatsos | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 12 Feb 2022 | 8,205 | 0 | - | - | Restricted Stock Unit | |
| Michel Vounatsos | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.59 per share. | 12 Feb 2022 | 4,699 | 63,816 (0%) | 0% | 214.6 | 1,008,358 | Common Stock |
| Chirfi Guindo | Head of Glob Prod Strat & Com | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 1,336 | 8,044 (0%) | 0% | 0 | Common Stock | |
| Chirfi Guindo | Head of Glob Prod Strat & Com | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.59 per share. | 12 Feb 2022 | 1,189 | 6,262 (0%) | 0% | 214.6 | 255,148 | Common Stock |
| Chirfi Guindo | Head of Glob Prod Strat & Com | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.59 per share. | 12 Feb 2022 | 593 | 7,451 (0%) | 0% | 214.6 | 127,252 | Common Stock |
| Chirfi Guindo | Head of Glob Prod Strat & Com | Other type of transaction at price $ 0.00 per share. | 12 Feb 2022 | 2,480 | 3,818 | - | - | Restricted Stock Unit | |
| Chirfi Guindo | Head of Glob Prod Strat & Com | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.59 per share. | 12 Feb 2022 | 560 | 6,708 (0%) | 0% | 214.6 | 120,170 | Common Stock |
| Chirfi Guindo | Head of Glob Prod Strat & Com | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 1,261 | 7,268 (0%) | 0% | 0 | Common Stock | |
| Chirfi Guindo | Head of Glob Prod Strat & Com | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 1,261 | 2,395 | - | - | Restricted Stock Unit | |
| Chirfi Guindo | Head of Glob Prod Strat & Com | Other type of transaction at price $ 0.00 per share. | 12 Feb 2022 | 2,395 | 0 | - | - | Restricted Stock Unit | |
| Chirfi Guindo | Head of Glob Prod Strat & Com | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 1,336 | 6,298 | - | - | Restricted Stock Unit | |
| Rachid Izzar | Head of Alzheimers Disease | Other type of transaction at price $ 0.00 per share. | 12 Feb 2022 | 651 | 1,006 | - | - | Restricted Stock Unit | |
| Rachid Izzar | Head of Alzheimers Disease | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 351 | 1,457 (0%) | 0% | 0 | Common Stock | |
| Rachid Izzar | Head of Alzheimers Disease | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.59 per share. | 12 Feb 2022 | 122 | 1,335 (0%) | 0% | 214.6 | 26,180 | Common Stock |
| Rachid Izzar | Head of Alzheimers Disease | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 351 | 1,657 | - | - | Restricted Stock Unit | |
| Nicole Murphy | Head of Pharm Ops and Tech | Other type of transaction at price $ 0.00 per share. | 12 Feb 2022 | 489 | 756 | - | - | Restricted Stock Unit | |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 263 | 1,245 | - | - | Restricted Stock Unit | |
| Nicole Murphy | Head of Pharm Ops and Tech | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.59 per share. | 12 Feb 2022 | 92 | 1,396 (0%) | 0% | 214.6 | 19,742 | Common Stock |
| Nicole Murphy | Head of Pharm Ops and Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 263 | 1,488 (0%) | 0% | 0 | Common Stock | |
| Michael R. Mcdonnell | EVP, Chief Financial Officer | 10 Feb 2022 | 9,770 | 9,770 | - | - | Restricted Stock Unit | ||
| Susan H. Alexander | EVP Chief Legal Off & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 7,725 | 7,725 | - | - | Restricted Stock Unit | |
| Ginger Gregory | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 6,475 | 6,475 | - | - | Restricted Stock Unit | |
| Robin C. Kramer | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 2,500 | 2,500 | - | - | Restricted Stock Unit | |
| Michel Vounatsos | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 28,405 | 28,405 | - | - | Restricted Stock Unit | |
| Chirfi Guindo | Head of Glob Prod Strat & Com | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 9,090 | 9,090 | - | - | Restricted Stock Unit | |
| Rachid Izzar | Head of Alzheimers Disease | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 4,545 | 4,545 | - | - | Restricted Stock Unit | |
| Nicole Murphy | Head of Pharm Ops and Tech | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 6,815 | 6,815 | - | - | Restricted Stock Unit | |
| Ginger Gregory | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 1,941 | 10,027 (0%) | 0% | 0 | Common Stock | |
| Robin C. Kramer | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 244 | 1,354 (0%) | 0% | 0 | Common Stock | |
| Michel Vounatsos | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 10,594 | 63,666 (0%) | 0% | 0 | Common Stock | |
| Chirfi Guindo | Head of Glob Prod Strat & Com | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 3,088 | 6,007 (0%) | 0% | 0 | Common Stock | |
| Alphonse Galdes | EVP Pharmaceutical Oper & Tech | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 658 | 5,064 (0%) | 0% | 0 | Common Stock |